Amtrust Financial Services’s ENVUE MEDICAL INC NEW FEED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9
Closed -$11.2K 15
2024
Q1
$11.2K Hold
9
0.01% 15
2023
Q4
$14.3K Hold
9
0.01% 15
2023
Q3
$24.4K Hold
9
0.01% 14
2023
Q2
$42.6K Hold
9
0.02% 15
2023
Q1
$42.6K Hold
9
0.02% 19
2022
Q4
$62.5K Hold
9
0.03% 18
2022
Q3
$114K Hold
9
0.06% 19
2022
Q2
$156K Hold
9
0.07% 19
2022
Q1
$288K Hold
9
0.11% 17
2021
Q4
$258K Buy
9
+3
+50% +$107K 0.12% 14
2021
Q3
$301K Hold
6
0.29% 22
2021
Q2
$124K Hold
6
0.09% 60
2021
Q1
$149K Hold
6
0.09% 71
2020
Q4
$112K Hold
6
0.05% 65
2020
Q3
$102K Hold
6
0.09% 54
2020
Q2
$329K Hold
6
0.36% 33
2020
Q1
$314K Hold
6
0.51% 33
2019
Q4
$417K Hold
6
0.42% 37
2019
Q3
$365K Hold
6
0.44% 30
2019
Q2
$424K Hold
6
0.41% 35
2019
Q1
$592K Hold
6
0.52% 30
2018
Q4
$529K Hold
6
0.71% 22
2018
Q3
$671K Hold
6
0.49% 39
2018
Q2
$700K Hold
6
0.5% 38
2018
Q1
$724K Hold
6
0.47% 37
2017
Q4
$716K Buy
+6
New +$721K 0.33% 53

Other funds holding FEED

Amtrust Financial Services's FEED Position: Q2 2024 in Review

Amtrust Financial Services sold out of ENVUE MEDICAL INC NEW (FEED) in Q2 2024, closing a stake of 9 shares — an estimated $11.2K sold.

Amtrust Financial Services first reported a position in FEED in Q4 2017 and held it in 26 quarters. The position peaked at $724K in Q1 2018. 6 funds tracked by Wall St. Rank hold FEED as of Q2 2024.

  • Amtrust Financial Services reported no remaining ENVUE MEDICAL INC NEW position as of Q2 2024 after selling out during the quarter.
  • Amtrust Financial Services sold 9 ENVUE MEDICAL INC NEW shares in Q2 2024, an estimated $11.2K.
  • Amtrust Financial Services first reported a position in ENVUE MEDICAL INC NEW in Q4 2017 and held it in 26 quarters.
  • Amtrust Financial Services's ENVUE MEDICAL INC NEW position peaked at $724K in Q1 2018.
  • 6 funds tracked by Wall St. Rank held ENVUE MEDICAL INC NEW as of Q2 2024.

Based on Amtrust Financial Services's 13F filing for Q2 2024, filed 6 Aug 2024.